Related Organization(s)

You just read:

DSP and Takeda Announce the Acceptance of the European Medicines Agency Submission of an Atypical Antipsychotic Agent Lurasidone

News provided by

Takeda Pharmaceutical Company Limited

Oct 25, 2012, 08:00 ET